Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation.
Colon tumors frequently harbor mutation in K-RAS and/or N-RAS, members of a GTPase family operating as a central hub for multiple key signaling pathways. While these proteins are strongly homologous, they exhibit diverse downstream effects on cell behavior. Utilizing an isogenic panel of human colon carcinoma cells bearing oncogenic mutations in K-RAS and/or N-RAS, we observed that K-RAS and double mutants similarly yield elevated apoptosis in response to treatment with TNFalpha compared to N-RAS mutants. Regardless, and in surprising contrast, key phospho-protein signals were more similar between N-RAS and dual mutants. This apparent contradiction could not be explained by any of the key signals individually, but a multi-pathway model constructed from the single-mutant cell line data was able to predict the behavior of the dual-mutant cell line. This success arises from a quantitative integration of multiple pro-apoptotic (pIkappaBalpha, pERK2) and pro-survival (pJNK, pHSP27) signals in manner not easily discerned from intuitive inspection.
Kreeger
Pamela K
PK
Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, 16-343, Cambridge, MA 02139, USA.
Wang
Yufang
Y
Haigis
Kevin M
KM
Lauffenburger
Douglas A
DA
D002460:Cell Line; D003106:Colon / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D016207:Cytokines / Q000187:drug effects / Q000276:immunology*; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D009154:Mutation; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*; D018631:ras Proteins / Q000235:genetics / Q000276:immunology*
D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D018631:ras Proteins
Cell. 2006 Mar 24;124(6):1225-39
16564013
Nat Rev Cancer. 2003 Jan;3(1):11-22
12509763
Nature. 2009 Nov 5;462(7269):44-5
19890318
Mol Syst Biol. 2007;3:150
18059445
Mol Cell Proteomics. 2005 Oct;4(10):1569-90
16030008
Curr Colorectal Cancer Rep. 2009 Apr 1;5(2):69-74
19756239
Nature. 1987 May 28-Jun 3;327(6120):298-303
2438556
Cancer Res. 2009 Oct 15;69(20):8191-9
19789336
Nat Rev Cancer. 2003 Jun;3(6):459-65
12778136
Oncogene. 2007 May 10;26(21):3051-9
17130841
Mol Cell Biol. 2002 Mar;22(5):1589-606
11839824
Gastroenterology. 1990 Aug;99(2):416-20
2194896
Science. 1993 Apr 2;260(5104):85-8
8465203
J Biol Chem. 2004 Aug 27;279(35):36680-8
15213223
Science. 2005 Dec 9;310(5754):1646-53
16339439
Nat Genet. 2008 May;40(5):600-8
18372904
Hepatology. 2008 Jul;48(1):276-88
18536058
PLoS Comput Biol. 2007 Jan 5;3(1):e4
17206861